Antibiotic Resistance in Microbial Keratitis: Ten-Year Experience of Corneal Scrapes in the United Kingdom
Purpose To determine the scale of antibiotic resistance in microbial keratitis in East Kent, United Kingdom. Design Retrospective, observational case series. Participants Corneal scrapes over a 10-year period to December 2008 were identified using the local microbiology database, which provided cult...
Saved in:
Published in | Ophthalmology (Rochester, Minn.) Vol. 118; no. 11; pp. 2161 - 2165 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.11.2011
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose To determine the scale of antibiotic resistance in microbial keratitis in East Kent, United Kingdom. Design Retrospective, observational case series. Participants Corneal scrapes over a 10-year period to December 2008 were identified using the local microbiology database, which provided culture results and antibiotic sensitivity-resistance profiles. Testing Isolate sensitivity to chloramphenicol, cefuroxime, gentamicin, and ciprofloxacin was determined by microdilution using the Microscan System (Siemens Diagnostics, Dearfield, IL). Main Outcome Measures Isolates were graded as sensitive, intermediate, or resistant to the tested antibiotics, with minimal inhibitory concentrations interpreted against breakpoints from the Clinical and Laboratory Standards Institute. Results There were 476 scrapes from 440 patients (female, 57.6%; mean age, 53.5 years). All samples were cultured. Culture was positive in 163 samples (34.2%), growing 172 organisms. Bacterial keratitis accounted for 162 isolates (94.2%), of which 99 (61.1%) were gram-negative. There was a general increase in the number of gram-negative isolates with time ( P =0.003). In vitro testing showed widespread gram-negative resistance to chloramphenicol (74.1%), with reducing sensitivity over the study period ( P =0.004). There was 97.3% sensitivity to combination gentamicin and cefuroxime, and 94.4% sensitivity to ciprofloxacin. Ciprofloxacin resistance was found in 8 (17.0%) of 47 gram-positive isolates tested, with no trend toward increasing resistance. Conclusions This study has documented the highest levels of gram-negative keratitis in any open retrospective survey to date and highlights a trend of increasing gram-negative infection. We have demonstrated reducing chloramphenicol sensitivity, with high sensitivity to combination gentamicin and cefuroxime, as well as ciprofloxacin. Gram-positive fluoroquinolone resistance was higher than previously reported in the United Kingdom, but showed no evidence of increasing resistance. Second-generation fluoroquinolone monotherapy remains the recommended empirical treatment in microbial keratitis in the United Kingdom, and a change to fourth-generation compounds is not advised. Continued testing is essential to monitor for increasing resistance. Financial Disclosure(s) The author(s) have no proprietary or commercial interest in any materials discussed in this article. |
---|---|
AbstractList | Purpose To determine the scale of antibiotic resistance in microbial keratitis in East Kent, United Kingdom. Design Retrospective, observational case series. Participants Corneal scrapes over a 10-year period to December 2008 were identified using the local microbiology database, which provided culture results and antibiotic sensitivity-resistance profiles. Testing Isolate sensitivity to chloramphenicol, cefuroxime, gentamicin, and ciprofloxacin was determined by microdilution using the Microscan System (Siemens Diagnostics, Dearfield, IL). Main Outcome Measures Isolates were graded as sensitive, intermediate, or resistant to the tested antibiotics, with minimal inhibitory concentrations interpreted against breakpoints from the Clinical and Laboratory Standards Institute. Results There were 476 scrapes from 440 patients (female, 57.6%; mean age, 53.5 years). All samples were cultured. Culture was positive in 163 samples (34.2%), growing 172 organisms. Bacterial keratitis accounted for 162 isolates (94.2%), of which 99 (61.1%) were gram-negative. There was a general increase in the number of gram-negative isolates with time ( P =0.003). In vitro testing showed widespread gram-negative resistance to chloramphenicol (74.1%), with reducing sensitivity over the study period ( P =0.004). There was 97.3% sensitivity to combination gentamicin and cefuroxime, and 94.4% sensitivity to ciprofloxacin. Ciprofloxacin resistance was found in 8 (17.0%) of 47 gram-positive isolates tested, with no trend toward increasing resistance. Conclusions This study has documented the highest levels of gram-negative keratitis in any open retrospective survey to date and highlights a trend of increasing gram-negative infection. We have demonstrated reducing chloramphenicol sensitivity, with high sensitivity to combination gentamicin and cefuroxime, as well as ciprofloxacin. Gram-positive fluoroquinolone resistance was higher than previously reported in the United Kingdom, but showed no evidence of increasing resistance. Second-generation fluoroquinolone monotherapy remains the recommended empirical treatment in microbial keratitis in the United Kingdom, and a change to fourth-generation compounds is not advised. Continued testing is essential to monitor for increasing resistance. Financial Disclosure(s) The author(s) have no proprietary or commercial interest in any materials discussed in this article. To determine the scale of antibiotic resistance in microbial keratitis in East Kent, United Kingdom. Retrospective, observational case series. Corneal scrapes over a 10-year period to December 2008 were identified using the local microbiology database, which provided culture results and antibiotic sensitivity-resistance profiles. Isolate sensitivity to chloramphenicol, cefuroxime, gentamicin, and ciprofloxacin was determined by microdilution using the Microscan System (Siemens Diagnostics, Dearfield, IL). Isolates were graded as sensitive, intermediate, or resistant to the tested antibiotics, with minimal inhibitory concentrations interpreted against breakpoints from the Clinical and Laboratory Standards Institute. There were 476 scrapes from 440 patients (female, 57.6%; mean age, 53.5 years). All samples were cultured. Culture was positive in 163 samples (34.2%), growing 172 organisms. Bacterial keratitis accounted for 162 isolates (94.2%), of which 99 (61.1%) were gram-negative. There was a general increase in the number of gram-negative isolates with time (P=0.003). In vitro testing showed widespread gram-negative resistance to chloramphenicol (74.1%), with reducing sensitivity over the study period (P=0.004). There was 97.3% sensitivity to combination gentamicin and cefuroxime, and 94.4% sensitivity to ciprofloxacin. Ciprofloxacin resistance was found in 8 (17.0%) of 47 gram-positive isolates tested, with no trend toward increasing resistance. This study has documented the highest levels of gram-negative keratitis in any open retrospective survey to date and highlights a trend of increasing gram-negative infection. We have demonstrated reducing chloramphenicol sensitivity, with high sensitivity to combination gentamicin and cefuroxime, as well as ciprofloxacin. Gram-positive fluoroquinolone resistance was higher than previously reported in the United Kingdom, but showed no evidence of increasing resistance. Second-generation fluoroquinolone monotherapy remains the recommended empirical treatment in microbial keratitis in the United Kingdom, and a change to fourth-generation compounds is not advised. Continued testing is essential to monitor for increasing resistance. The author(s) have no proprietary or commercial interest in any materials discussed in this article. PURPOSETo determine the scale of antibiotic resistance in microbial keratitis in East Kent, United Kingdom.DESIGNRetrospective, observational case series.PARTICIPANTSCorneal scrapes over a 10-year period to December 2008 were identified using the local microbiology database, which provided culture results and antibiotic sensitivity-resistance profiles.TESTINGIsolate sensitivity to chloramphenicol, cefuroxime, gentamicin, and ciprofloxacin was determined by microdilution using the Microscan System (Siemens Diagnostics, Dearfield, IL).MAIN OUTCOME MEASURESIsolates were graded as sensitive, intermediate, or resistant to the tested antibiotics, with minimal inhibitory concentrations interpreted against breakpoints from the Clinical and Laboratory Standards Institute.RESULTSThere were 476 scrapes from 440 patients (female, 57.6%; mean age, 53.5 years). All samples were cultured. Culture was positive in 163 samples (34.2%), growing 172 organisms. Bacterial keratitis accounted for 162 isolates (94.2%), of which 99 (61.1%) were gram-negative. There was a general increase in the number of gram-negative isolates with time (P=0.003). In vitro testing showed widespread gram-negative resistance to chloramphenicol (74.1%), with reducing sensitivity over the study period (P=0.004). There was 97.3% sensitivity to combination gentamicin and cefuroxime, and 94.4% sensitivity to ciprofloxacin. Ciprofloxacin resistance was found in 8 (17.0%) of 47 gram-positive isolates tested, with no trend toward increasing resistance.CONCLUSIONSThis study has documented the highest levels of gram-negative keratitis in any open retrospective survey to date and highlights a trend of increasing gram-negative infection. We have demonstrated reducing chloramphenicol sensitivity, with high sensitivity to combination gentamicin and cefuroxime, as well as ciprofloxacin. Gram-positive fluoroquinolone resistance was higher than previously reported in the United Kingdom, but showed no evidence of increasing resistance. Second-generation fluoroquinolone monotherapy remains the recommended empirical treatment in microbial keratitis in the United Kingdom, and a change to fourth-generation compounds is not advised. Continued testing is essential to monitor for increasing resistance.FINANCIAL DISCLOSURE(S)The author(s) have no proprietary or commercial interest in any materials discussed in this article. |
Author | Gurbaxani, Avinash, MBBS, MRCS(Ed) (Ophth) Baker, Mark, PhD, FIBMS Nash, James, FRCPath Shalchi, Zaid, MBBS, BSc |
Author_xml | – sequence: 1 fullname: Shalchi, Zaid, MBBS, BSc – sequence: 2 fullname: Gurbaxani, Avinash, MBBS, MRCS(Ed) (Ophth) – sequence: 3 fullname: Baker, Mark, PhD, FIBMS – sequence: 4 fullname: Nash, James, FRCPath |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24729550$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21764458$$D View this record in MEDLINE/PubMed |
BookMark | eNqFksFu1DAQhi1URLeFN0AoF8Qpy9hxnIQDUrUqLWoREl0OnCzHGbNesnZqexF9exx2AYkLJ1--f_7xpzkjJ847JOQ5hSUFKl5vl37apI1aMqB0CXwJjD4iC1rzruQNrU7IImO0FJzBKTmLcQsAQlT8CTlltBGc1-2CbC9csr31yeriE0Ybk3IaC-uKD1YH31s1FjcYVLLJxjfFGl35BVUoLn9MGCzOrDfFygeHmbzTQU0Y53jaYPHZ2YRDcWPd18HvnpLHRo0Rnx3fc7J-d7leXZe3H6_ery5uS11TlkqNbWf6tu7EUDe1EYapvgU2iEprRrUB0UOnQXTC0I5qDcZo3kPT9BX01FTn5NVh7BT8_R5jkjsbNY6jcuj3UXbAqop1HWSSH8j80RgDGjkFu1PhQVKQs2O5lQfHcnYsgcvsOMdeHAv2_Q6HP6HfUjPw8gioqNVoQlZq41-ON6yr67n_7YHDbOO7xSCj_qV0sAF1koO3_9vk3wF6tM7mzm_4gHHr98Fl05LKyCTIu_ke5nOgFIBD21Y_Aetesvc |
CODEN | OPHTDG |
CitedBy_id | crossref_primary_10_1016_j_exer_2021_108476 crossref_primary_10_1097_ICO_0000000000002830 crossref_primary_10_1097_ICO_0000000000000734 crossref_primary_10_1016_j_ajo_2014_09_021 crossref_primary_10_1371_journal_pone_0213103 crossref_primary_10_33321_cdi_2020_44_86 crossref_primary_10_1016_j_yoph_2012_03_041 crossref_primary_10_1186_s41182_023_00496_x crossref_primary_10_3341_kjo_2022_0064 crossref_primary_10_1097_MD_0000000000011318 crossref_primary_10_3390_jcm10235671 crossref_primary_10_1186_s12886_020_1306_8 crossref_primary_10_1097_ICL_0000000000000993 crossref_primary_10_1371_journal_pone_0165223 crossref_primary_10_1007_s40135_013_0022_4 crossref_primary_10_3341_jkos_2021_62_4_447 crossref_primary_10_1071_HI15014 crossref_primary_10_1111_vop_12480 crossref_primary_10_1111_ceo_13672 crossref_primary_10_1097_ICO_0000000000000428 crossref_primary_10_1136_bjophthalmol_2018_312881 crossref_primary_10_1080_02713683_2023_2288803 crossref_primary_10_1097_ICO_0000000000003179 crossref_primary_10_1038_s41598_021_93172_1 crossref_primary_10_1136_bjophthalmol_2016_310026 crossref_primary_10_1016_j_jtos_2022_05_004 crossref_primary_10_1097_ICL_0b013e3182a3024e crossref_primary_10_1097_ICO_0000000000001390 crossref_primary_10_4103_ijo_IJO_1438_22 crossref_primary_10_1016_j_preteyeres_2021_101031 crossref_primary_10_1111_aos_14789 crossref_primary_10_1136_bmjopen_2022_069338 crossref_primary_10_1016_j_jcjo_2014_12_013 crossref_primary_10_1111_ceo_13364 crossref_primary_10_1155_2012_831502 crossref_primary_10_1155_2015_769436 crossref_primary_10_3390_proteomes3040496 crossref_primary_10_4274_tjo_galenos_2021_98046 crossref_primary_10_1038_s41433_020_01378_w crossref_primary_10_1136_bmjophth_2022_001002 crossref_primary_10_1097_ICO_0000000000000352 crossref_primary_10_1155_2013_369094 crossref_primary_10_3341_jkos_2021_62_11_1465 crossref_primary_10_1080_02713683_2018_1461907 crossref_primary_10_1016_j_pdpdt_2022_102717 crossref_primary_10_3341_jkos_2014_55_10_1432 crossref_primary_10_1038_eye_2015_250 crossref_primary_10_1136_bjophthalmol_2015_307371 crossref_primary_10_1097_ICL_0000000000000173 crossref_primary_10_1016_j_ophtha_2012_03_031 crossref_primary_10_1186_s12879_019_4418_0 crossref_primary_10_3389_fcimb_2023_1250257 crossref_primary_10_1016_j_jcjo_2022_08_012 crossref_primary_10_13181_mji_v24i3_1044 crossref_primary_10_1016_j_jcjo_2017_11_001 crossref_primary_10_1097_ICL_0000000000000298 crossref_primary_10_1016_j_jfo_2023_07_019 crossref_primary_10_18008_1816_5095_2023_1_17_23 crossref_primary_10_7883_yoken_JJID_2018_269 crossref_primary_10_1016_j_survophthal_2018_12_003 crossref_primary_10_1097_ICO_0000000000000844 crossref_primary_10_1155_2019_6328058 crossref_primary_10_2147_OPTH_S395877 crossref_primary_10_3390_jpm13030519 crossref_primary_10_1111_ceo_12723 crossref_primary_10_3341_jkos_2019_60_11_1027 crossref_primary_10_1177_0300060513505957 crossref_primary_10_3341_jkos_2024_65_3_181 crossref_primary_10_1136_bjophthalmol_2017_311751 crossref_primary_10_2174_2212796816666220419121948 crossref_primary_10_1016_j_ajo_2023_06_016 crossref_primary_10_1016_j_ophtha_2014_11_027 crossref_primary_10_3390_diagnostics12092095 crossref_primary_10_1097_ICL_0000000000000883 crossref_primary_10_1097_ICL_0b013e3182a3026b |
Cites_doi | 10.1016/S0161-6420(00)00179-2 10.1111/j.1442-9071.2004.00867.x 10.1016/S0161-6420(99)00717-4 10.1128/AAC.34.11.2050 10.1016/S0161-6420(99)00716-2 10.1038/eye.1998.221 10.1016/j.survophthal.2005.05.001 10.1016/j.ajo.2004.03.016 10.1097/00055735-200408000-00007 10.1016/S0161-6420(99)90008-8 10.1128/AAC.34.9.1862 10.1016/S0002-9394(03)00294-0 10.1016/S0161-6420(97)30009-8 10.1097/ICO.0b013e318156caf2 10.1136/bjo.84.7.687 10.1093/jac/26.suppl_F.165 10.1016/S0002-9394(03)00905-X 10.1136/bjo.87.7.834 10.1093/jac/37.2.243 10.1016/j.ajo.2006.06.030 10.1046/j.1469-0691.2003.00696.x 10.1097/01.icl.0000237825.98225.ca 10.1001/archopht.1995.01100100045026 10.1016/j.ophtha.2004.09.029 10.2165/00003088-199019060-00003 10.1016/j.survophthal.2005.05.005 |
ContentType | Journal Article |
Copyright | American Academy of Ophthalmology 2011 American Academy of Ophthalmology 2015 INIST-CNRS Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: American Academy of Ophthalmology – notice: 2011 American Academy of Ophthalmology – notice: 2015 INIST-CNRS – notice: Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.ophtha.2011.04.021 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1549-4713 |
EndPage | 2165 |
ExternalDocumentID | 10_1016_j_ophtha_2011_04_021 21764458 24729550 S0161642011004088 1_s2_0_S0161642011004088 |
Genre | Journal Article |
GeographicLocations | United Kingdom Europe |
GroupedDBID | - 08R 0R 1- 123 1B1 1P 1~5 29N 4.4 457 4G. 53G 55 5RE 5VS 7-5 71M AAEDT AAIAV AALRI AALRV AAQFI AAQQT AAQXK AAXUO ABFLS ABFRF ABIID ABLJU ABMAC ABOCM ABPTK ABQIS ABWYI ACGFO ACGFS ACIUM ACNCT ADPAM AEFWE AENEX AEVXI AFFNX AFRHN AFTJW AGZHU AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS ALXNB BELOY C5W CS3 DU5 EBS EFJIC EJD F5P FDB FEDTE FGOYB FO GBLVA GJ HVGLF HZ IHE IPNFZ J1W K K-O KOM L7B M27 M41 MO0 N4W N9A NQ- O9- OF- OPF OQ P2P R2- RIG ROL RPZ SDG SEL SES SSZ UHS UNMZH UV1 WH7 X7M XH2 XPP Z5R ZA5 ZGI ZXP --- --K .1- .55 .FO .GJ 0R~ 1P~ AAEDW ABCQX ABJNI ADMUD AHPSJ AMRAJ HZ~ OQ~ AAUGY IQODW AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c512t-ce89fb8596d575f6f2ab802d63cc21cf06b09c0696f191cc0ffc4b077b30b1f3 |
ISSN | 0161-6420 |
IngestDate | Fri Aug 16 10:20:38 EDT 2024 Fri Aug 23 03:15:25 EDT 2024 Thu May 23 23:17:16 EDT 2024 Sun Oct 22 16:04:32 EDT 2023 Fri Feb 23 02:14:11 EST 2024 Thu Aug 18 18:35:47 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Resistance Eye disease Antibiotic Cornea Keratitis Keratopathy Ophthalmology Anterior segment disease |
Language | English |
License | CC BY 4.0 Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c512t-ce89fb8596d575f6f2ab802d63cc21cf06b09c0696f191cc0ffc4b077b30b1f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 21764458 |
PQID | 902332990 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_902332990 crossref_primary_10_1016_j_ophtha_2011_04_021 pubmed_primary_21764458 pascalfrancis_primary_24729550 elsevier_sciencedirect_doi_10_1016_j_ophtha_2011_04_021 elsevier_clinicalkeyesjournals_1_s2_0_S0161642011004088 |
PublicationCentury | 2000 |
PublicationDate | 2011-11-01 |
PublicationDateYYYYMMDD | 2011-11-01 |
PublicationDate_xml | – month: 11 year: 2011 text: 2011-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Ophthalmology (Rochester, Minn.) |
PublicationTitleAlternate | Ophthalmology |
PublicationYear | 2011 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Schlech, Blondeau (bib22) 2005; 50 O'Brien, Maguire, Fink (bib3) 1995; 113 Chalita, Höfling-Lima, Paranhos (bib19) 2004; 137 Soussy, Nguyen, Goldstein (bib27) 2003; 9 Scheel, Lyon, Rosdahl (bib8) 1996; 37 Alexandrakis, Alfonso, Miller (bib10) 2000; 107 Daum, Schaberg, Terpenning (bib5) 1990; 34 Walker, Diaper, Bowman (bib18) 1998; 12 Raviglione, Boyle, Mariuz (bib6) 1990; 34 Ball (bib7) 1990; 26 Bourcier, Thomas, Borderie (bib17) 2003; 87 Alfonso, Crider (bib23) 2005; 50 Mah (bib2) 2004; 15 Rhee, Kowalski, Romanowski (bib26) 2004; 138 Solomon, Donnenfeld, Perry (bib24) 2005; 112 Kotlus, Wymbs, Vellozzi, Udell (bib20) 2006; 142 Garg, Sharma, Rao (bib21) 1999; 106 Goldstein, Kowalski, Gordon (bib9) 1999; 106 Green, Apel, Stapleton (bib15) 2008; 27 Rajpal, Hall, Long, Wells (bib16) 2007; 120 (bib1) 1997; 104 Hall, McKellar (bib14) 2004; 32 Kunimoto, Sharma, Garg, Rao (bib11) 1999; 106 Kowalski, Dhaliwal, Karenchak (bib25) 2003; 136 Tuft, Matheson (bib12) 2000; 84 Vance-Bryan, Guay, Rotschafer (bib4) 1990; 19 Toshida, Kogure, Inoue, Murakami (bib13) 2007; 33 Kowalski (10.1016/j.ophtha.2011.04.021_bib25) 2003; 136 Hall (10.1016/j.ophtha.2011.04.021_bib14) 2004; 32 Daum (10.1016/j.ophtha.2011.04.021_bib5) 1990; 34 Ball (10.1016/j.ophtha.2011.04.021_bib7) 1990; 26 Toshida (10.1016/j.ophtha.2011.04.021_bib13) 2007; 33 Soussy (10.1016/j.ophtha.2011.04.021_bib27) 2003; 9 Goldstein (10.1016/j.ophtha.2011.04.021_bib9) 1999; 106 Chalita (10.1016/j.ophtha.2011.04.021_bib19) 2004; 137 (10.1016/j.ophtha.2011.04.021_bib1) 1997; 104 Green (10.1016/j.ophtha.2011.04.021_bib15) 2008; 27 Kunimoto (10.1016/j.ophtha.2011.04.021_bib11) 1999; 106 Rhee (10.1016/j.ophtha.2011.04.021_bib26) 2004; 138 Bourcier (10.1016/j.ophtha.2011.04.021_bib17) 2003; 87 Walker (10.1016/j.ophtha.2011.04.021_bib18) 1998; 12 O'Brien (10.1016/j.ophtha.2011.04.021_bib3) 1995; 113 Solomon (10.1016/j.ophtha.2011.04.021_bib24) 2005; 112 Alexandrakis (10.1016/j.ophtha.2011.04.021_bib10) 2000; 107 Tuft (10.1016/j.ophtha.2011.04.021_bib12) 2000; 84 Garg (10.1016/j.ophtha.2011.04.021_bib21) 1999; 106 Raviglione (10.1016/j.ophtha.2011.04.021_bib6) 1990; 34 Scheel (10.1016/j.ophtha.2011.04.021_bib8) 1996; 37 Alfonso (10.1016/j.ophtha.2011.04.021_bib23) 2005; 50 Mah (10.1016/j.ophtha.2011.04.021_bib2) 2004; 15 Schlech (10.1016/j.ophtha.2011.04.021_bib22) 2005; 50 Vance-Bryan (10.1016/j.ophtha.2011.04.021_bib4) 1990; 19 Kotlus (10.1016/j.ophtha.2011.04.021_bib20) 2006; 142 Rajpal (10.1016/j.ophtha.2011.04.021_bib16) 2007; 120 |
References_xml | – volume: 34 start-page: 2050 year: 1990 end-page: 2054 ident: bib6 article-title: Ciprofloxacin-resistant methicillin-resistant publication-title: Antimicrob Agents Chemother contributor: fullname: Mariuz – volume: 138 start-page: 226 year: 2004 end-page: 230 ident: bib26 article-title: A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa publication-title: Am J Ophthalmol contributor: fullname: Romanowski – volume: 113 start-page: 1257 year: 1995 end-page: 1265 ident: bib3 article-title: Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis: report from the Bacterial Keratitis Study Research Group publication-title: Arch Ophthalmol contributor: fullname: Fink – volume: 120 start-page: U2682 year: 2007 ident: bib16 article-title: Five-year experience of corneal scrapes at Wellington Eye Department, New Zealand publication-title: N Z Med J contributor: fullname: Wells – volume: 9 start-page: 997 year: 2003 end-page: 1005 ident: bib27 article-title: In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study publication-title: Clin Microbiol Infect contributor: fullname: Goldstein – volume: 19 start-page: 434 year: 1990 end-page: 461 ident: bib4 article-title: Clinical pharmacokinetics of ciprofloxacin publication-title: Clin Pharmacokinet contributor: fullname: Rotschafer – volume: 15 start-page: 316 year: 2004 end-page: 320 ident: bib2 article-title: Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections publication-title: Curr Opin Ophthalmol contributor: fullname: Mah – volume: 34 start-page: 1862 year: 1990 end-page: 1863 ident: bib5 article-title: Increasing resistance of publication-title: Antimicrob Agents Chemother contributor: fullname: Terpenning – volume: 84 start-page: 687 year: 2000 end-page: 691 ident: bib12 article-title: In vitro antibiotic resistance in bacterial keratitis in London publication-title: Br J Ophthalmol contributor: fullname: Matheson – volume: 106 start-page: 1319 year: 1999 end-page: 1323 ident: bib21 article-title: Ciprofloxacin-resistant Pseudomonas keratitis publication-title: Ophthalmology contributor: fullname: Rao – volume: 137 start-page: 43 year: 2004 end-page: 51 ident: bib19 article-title: Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years publication-title: Am J Ophthalmol contributor: fullname: Paranhos – volume: 32 start-page: 478 year: 2004 end-page: 481 ident: bib14 article-title: Bacterial keratitis in Christchurch, New Zealand, 1997-2001 publication-title: Clin Experiment Ophthalmol contributor: fullname: McKellar – volume: 37 start-page: 243 year: 1996 end-page: 251 ident: bib8 article-title: In-vitro susceptibility of isolates of methicillin-resistant publication-title: J Antimicrob Chemother contributor: fullname: Rosdahl – volume: 50 start-page: S64 year: 2005 end-page: S67 ident: bib22 article-title: Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) publication-title: Surv Ophthalmol contributor: fullname: Blondeau – volume: 106 start-page: 1313 year: 1999 end-page: 1318 ident: bib9 article-title: Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review publication-title: Ophthalmology contributor: fullname: Gordon – volume: 12 start-page: 875 year: 1998 end-page: 879 ident: bib18 article-title: Lack of evidence for systemic toxicity following topical chloramphenicol use publication-title: Eye (Lond) contributor: fullname: Bowman – volume: 106 start-page: 80 year: 1999 end-page: 85 ident: bib11 article-title: In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin: emerging resistance publication-title: Ophthalmology contributor: fullname: Rao – volume: 50 start-page: S1 year: 2005 end-page: S6 ident: bib23 article-title: Ophthalmic infections and their anti-infective challenges publication-title: Surv Ophthalmol contributor: fullname: Crider – volume: 33 start-page: 70 year: 2007 end-page: 73 ident: bib13 article-title: Trends in microbial keratitis in Japan publication-title: Eye Contact Lens contributor: fullname: Murakami – volume: 136 start-page: 500 year: 2003 end-page: 505 ident: bib25 article-title: Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates publication-title: Am J Ophthalmol contributor: fullname: Karenchak – volume: 142 start-page: 726 year: 2006 end-page: 729 ident: bib20 article-title: In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates publication-title: Am J Ophthalmol contributor: fullname: Udell – volume: 104 start-page: 1902 year: 1997 end-page: 1909 ident: bib1 article-title: Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy publication-title: Ophthalmology – volume: 27 start-page: 22 year: 2008 end-page: 27 ident: bib15 article-title: Risk factors and causative organisms in microbial keratitis publication-title: Cornea contributor: fullname: Stapleton – volume: 107 start-page: 1497 year: 2000 end-page: 1502 ident: bib10 article-title: Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones publication-title: Ophthalmology contributor: fullname: Miller – volume: 26 start-page: 165 year: 1990 end-page: 179 ident: bib7 article-title: Emergent resistance to ciprofloxacin amongst publication-title: J Antimicrob Chemother contributor: fullname: Ball – volume: 87 start-page: 834 year: 2003 end-page: 838 ident: bib17 article-title: Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases publication-title: Br J Ophthalmol contributor: fullname: Borderie – volume: 112 start-page: 466 year: 2005 end-page: 469 ident: bib24 article-title: Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor publication-title: Ophthalmology contributor: fullname: Perry – volume: 107 start-page: 1497 year: 2000 ident: 10.1016/j.ophtha.2011.04.021_bib10 article-title: Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones publication-title: Ophthalmology doi: 10.1016/S0161-6420(00)00179-2 contributor: fullname: Alexandrakis – volume: 32 start-page: 478 year: 2004 ident: 10.1016/j.ophtha.2011.04.021_bib14 article-title: Bacterial keratitis in Christchurch, New Zealand, 1997-2001 publication-title: Clin Experiment Ophthalmol doi: 10.1111/j.1442-9071.2004.00867.x contributor: fullname: Hall – volume: 106 start-page: 1319 year: 1999 ident: 10.1016/j.ophtha.2011.04.021_bib21 article-title: Ciprofloxacin-resistant Pseudomonas keratitis publication-title: Ophthalmology doi: 10.1016/S0161-6420(99)00717-4 contributor: fullname: Garg – volume: 34 start-page: 2050 year: 1990 ident: 10.1016/j.ophtha.2011.04.021_bib6 article-title: Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.34.11.2050 contributor: fullname: Raviglione – volume: 106 start-page: 1313 year: 1999 ident: 10.1016/j.ophtha.2011.04.021_bib9 article-title: Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review publication-title: Ophthalmology doi: 10.1016/S0161-6420(99)00716-2 contributor: fullname: Goldstein – volume: 12 start-page: 875 year: 1998 ident: 10.1016/j.ophtha.2011.04.021_bib18 article-title: Lack of evidence for systemic toxicity following topical chloramphenicol use publication-title: Eye (Lond) doi: 10.1038/eye.1998.221 contributor: fullname: Walker – volume: 50 start-page: S1 issue: Suppl year: 2005 ident: 10.1016/j.ophtha.2011.04.021_bib23 article-title: Ophthalmic infections and their anti-infective challenges publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2005.05.001 contributor: fullname: Alfonso – volume: 138 start-page: 226 year: 2004 ident: 10.1016/j.ophtha.2011.04.021_bib26 article-title: A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2004.03.016 contributor: fullname: Rhee – volume: 15 start-page: 316 year: 2004 ident: 10.1016/j.ophtha.2011.04.021_bib2 article-title: Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections publication-title: Curr Opin Ophthalmol doi: 10.1097/00055735-200408000-00007 contributor: fullname: Mah – volume: 106 start-page: 80 year: 1999 ident: 10.1016/j.ophtha.2011.04.021_bib11 article-title: In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin: emerging resistance publication-title: Ophthalmology doi: 10.1016/S0161-6420(99)90008-8 contributor: fullname: Kunimoto – volume: 34 start-page: 1862 year: 1990 ident: 10.1016/j.ophtha.2011.04.021_bib5 article-title: Increasing resistance of Staphylococcus aureus to ciprofloxacin publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.34.9.1862 contributor: fullname: Daum – volume: 136 start-page: 500 year: 2003 ident: 10.1016/j.ophtha.2011.04.021_bib25 article-title: Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(03)00294-0 contributor: fullname: Kowalski – volume: 104 start-page: 1902 year: 1997 ident: 10.1016/j.ophtha.2011.04.021_bib1 article-title: Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy publication-title: Ophthalmology doi: 10.1016/S0161-6420(97)30009-8 – volume: 27 start-page: 22 year: 2008 ident: 10.1016/j.ophtha.2011.04.021_bib15 article-title: Risk factors and causative organisms in microbial keratitis publication-title: Cornea doi: 10.1097/ICO.0b013e318156caf2 contributor: fullname: Green – volume: 84 start-page: 687 year: 2000 ident: 10.1016/j.ophtha.2011.04.021_bib12 article-title: In vitro antibiotic resistance in bacterial keratitis in London publication-title: Br J Ophthalmol doi: 10.1136/bjo.84.7.687 contributor: fullname: Tuft – volume: 26 start-page: 165 issue: Suppl year: 1990 ident: 10.1016/j.ophtha.2011.04.021_bib7 article-title: Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches publication-title: J Antimicrob Chemother doi: 10.1093/jac/26.suppl_F.165 contributor: fullname: Ball – volume: 137 start-page: 43 year: 2004 ident: 10.1016/j.ophtha.2011.04.021_bib19 article-title: Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(03)00905-X contributor: fullname: Chalita – volume: 87 start-page: 834 year: 2003 ident: 10.1016/j.ophtha.2011.04.021_bib17 article-title: Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases publication-title: Br J Ophthalmol doi: 10.1136/bjo.87.7.834 contributor: fullname: Bourcier – volume: 37 start-page: 243 year: 1996 ident: 10.1016/j.ophtha.2011.04.021_bib8 article-title: In-vitro susceptibility of isolates of methicillin-resistant Staphylococcus aureus 1988-1993 publication-title: J Antimicrob Chemother doi: 10.1093/jac/37.2.243 contributor: fullname: Scheel – volume: 142 start-page: 726 year: 2006 ident: 10.1016/j.ophtha.2011.04.021_bib20 article-title: In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2006.06.030 contributor: fullname: Kotlus – volume: 9 start-page: 997 year: 2003 ident: 10.1016/j.ophtha.2011.04.021_bib27 article-title: In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study publication-title: Clin Microbiol Infect doi: 10.1046/j.1469-0691.2003.00696.x contributor: fullname: Soussy – volume: 33 start-page: 70 year: 2007 ident: 10.1016/j.ophtha.2011.04.021_bib13 article-title: Trends in microbial keratitis in Japan publication-title: Eye Contact Lens doi: 10.1097/01.icl.0000237825.98225.ca contributor: fullname: Toshida – volume: 113 start-page: 1257 year: 1995 ident: 10.1016/j.ophtha.2011.04.021_bib3 article-title: Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis: report from the Bacterial Keratitis Study Research Group publication-title: Arch Ophthalmol doi: 10.1001/archopht.1995.01100100045026 contributor: fullname: O'Brien – volume: 112 start-page: 466 year: 2005 ident: 10.1016/j.ophtha.2011.04.021_bib24 article-title: Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor publication-title: Ophthalmology doi: 10.1016/j.ophtha.2004.09.029 contributor: fullname: Solomon – volume: 120 start-page: U2682 year: 2007 ident: 10.1016/j.ophtha.2011.04.021_bib16 article-title: Five-year experience of corneal scrapes at Wellington Eye Department, New Zealand publication-title: N Z Med J contributor: fullname: Rajpal – volume: 19 start-page: 434 year: 1990 ident: 10.1016/j.ophtha.2011.04.021_bib4 article-title: Clinical pharmacokinetics of ciprofloxacin publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199019060-00003 contributor: fullname: Vance-Bryan – volume: 50 start-page: S64 issue: Suppl year: 2005 ident: 10.1016/j.ophtha.2011.04.021_bib22 article-title: Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2005.05.005 contributor: fullname: Schlech |
SSID | ssj0006634 |
Score | 2.394258 |
Snippet | Purpose To determine the scale of antibiotic resistance in microbial keratitis in East Kent, United Kingdom. Design Retrospective, observational case series.... To determine the scale of antibiotic resistance in microbial keratitis in East Kent, United Kingdom. Retrospective, observational case series. Corneal scrapes... PURPOSETo determine the scale of antibiotic resistance in microbial keratitis in East Kent, United Kingdom.DESIGNRetrospective, observational case... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2161 |
SubjectTerms | Adult Aged Aged, 80 and over Anti-Bacterial Agents - pharmacology Bacteria - drug effects Bacteria - isolation & purification Bacteriological Techniques Biological and medical sciences Cefuroxime - pharmacology Ciprofloxacin - pharmacology Cornea - microbiology Corneal Ulcer - drug therapy Corneal Ulcer - epidemiology Corneal Ulcer - microbiology Diseases of cornea, anterior segment and sclera Drug Resistance, Bacterial Eye Infections, Bacterial - drug therapy Eye Infections, Bacterial - epidemiology Eye Infections, Bacterial - microbiology Female Gentamicins - pharmacology Humans Male Medical sciences Microbial Sensitivity Tests Middle Aged Miscellaneous Ophthalmology Retrospective Studies United Kingdom - epidemiology |
Title | Antibiotic Resistance in Microbial Keratitis: Ten-Year Experience of Corneal Scrapes in the United Kingdom |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0161642011004088 https://dx.doi.org/10.1016/j.ophtha.2011.04.021 https://www.ncbi.nlm.nih.gov/pubmed/21764458 https://search.proquest.com/docview/902332990 |
Volume | 118 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqTUJICHFfuUx-4DVVrnaCxEM2AYWyIm2dKE9W7CRaK3CqJeWBf8U_5Di2kxQ2DXiJ2lS51Ofzufk7xwi9pH5OApoXTk4j7oRZyJ0scQOHquZxpcuT2FPFySdzMj0PPyyj5Wj0c8Ba2jZ8In5cWVfyP1KFcyBXVSX7D5Ltbgon4DPIF44gYTj-lYxTqSo-qqYlw9fKE1TTdCUVGV71V4Lhn6mmyapvkc6jS-eL6tzTNzhu6RjVpSzariCqFKu21EfjjqpdT3L98taL_bS5aC6yr990_6Y2CWH23dJMfCkngwzD2TT9eDx93y6DZJZAv3397vz0KF2m8_aH9PtKZnWXmj5KZ5qhMSwlmqdn047YO8xWKLrcTrbCltEMM5rEcyAI0oszhdHCYeKA1Qx21HSvp7e2VqXTurqhu7Hg8DW60jroRMV6UrWjZPq3hhPX93praBkAvxnJjrrohxCORCpLtO_TJIJ4fz-dnX6edeYfXDjTUF7_L1uv2ZIK_3zydf7QnU1Wwywt9fYq18c_rR-0uIfumgAGpxqN99GokA_QrRND0XiI1j0ocQ9KvJK4AyXuQPkKW0jiHpK4KrGBJDaQVJcDJLGGJDaQfIQWb98sjqeO2dDDEeBXNo4o4qTkcZSQHKKEkpR-xmNXaQshfE-ULuFuIlySkNJLPCHcshQhdynlgcu9MniM9mQliwOE44JSknFCIh9C3DznQRhHRFCRhGEMdmuMHDuqbKPbtjDLZ1wzLQWmpMDckIEUxojaoWe2JBmMaFGb2V4zj9U-cxUZknhKrG2rRTDRwyuN06qdUQaou-GZhzsy7l7UQmyMsBU6A6WvVvIyWVTbmiXgaQfKkRyjJxoM_cUehRAnip_edPdn6HY_QZ-jveZyW7wAB7vhhwbSvwC16c3M |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibiotic+Resistance+in+Microbial+Keratitis%3A+Ten-Year+Experience+of+Corneal+Scrapes+in+the+United+Kingdom&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=SHALCHI%2C+Zaid&rft.au=GURBAXANI%2C+Avinash&rft.au=BAKER%2C+Mark&rft.au=NASH%2C+James&rft.date=2011-11-01&rft.pub=Elsevier&rft.issn=0161-6420&rft.eissn=1549-4713&rft.volume=118&rft.issue=11&rft.spage=2161&rft.epage=2165&rft_id=info:doi/10.1016%2Fj.ophtha.2011.04.021&rft.externalDBID=n%2Fa&rft.externalDocID=24729550 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642011X00106%2Fcov150h.gif |